Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits protective HIV-specific immune responses

Simple item page
dc.contributor.authorTomusange, K.
dc.contributor.authorWijesundara, D.
dc.contributor.authorGummow, J.
dc.contributor.authorGowans, E.J.
dc.contributor.authorGrubor-Bauk, B.
dc.contributor.conferenceConference on HIV Research for Prevention (HIV R4P) (17 Oct 2016 - 20 Oct 2016 : Chicago, IL)
dc.date.issued2016
dc.descriptionPoster 19: Novel vaccine and prevention concepts - P19.46LB
dc.description.statementofresponsibilityKhamis Tomusange, Danushka Wijesundara, Jason Gummow, Eric James. Gowans, Branka Grubor-Bauk
dc.identifier.citationAIDS Research and Human Retroviruses, 2016, vol.32, iss.Suppl. 1, pp.344-344
dc.identifier.doi10.1089/aid.2016.5000.abstracts
dc.identifier.issn0889-2229
dc.identifier.issn1931-8405
dc.identifier.orcidWijesundara, D. [0000-0002-0740-8362]
dc.identifier.orcidGummow, J. [0000-0002-6911-1206]
dc.identifier.orcidGowans, E.J. [0000-0002-4274-8311]
dc.identifier.orcidGrubor-Bauk, B. [0000-0002-4642-105X]
dc.identifier.urihttp://hdl.handle.net/2440/104088
dc.language.isoen
dc.publisherMary Ann Liebert
dc.rightsCopyright status unknown
dc.source.urihttps://doi.org/10.1089/aid.2016.5000.abstracts
dc.titleMucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits protective HIV-specific immune responses
dc.typeConference item
pubs.publication-statusPublished

Files

Collections

Medicine publications